Brand journalism: sponsored content/the 1A

Brand Journalism,
Sponsored Content and the First Amendment
 
Moderator:   Scott Dailard, Cooley LLP
 
Mary K. Engle,
Federal Trade Commission, Associate Director, Division of Advertising Practices:
We’re going to proceed as if there is a commercial/noncommercial divide.  To hold otherwise would upend FTC, FDA, SEC,
USDA—lots of regulations regulate speech. FTC: most based on idea that false
and misleading commercial speech is not protected by the 1A.  RJR advertorial: “on cigarettes and science”—FTC
elaborated on Bolger factors: does it
promote demand for product/service; does it refer to specific product/service
(whether or not brand specific); does it include info about product/service
attributes such as price/quality/health effects. Means used to publish speech,
including whether paid-for ads; speaker’s economic or commercial
motivation.  Used this standard a few
years ago for Pom Wonderful for
claims made in media appearances by Pom executives.
 
Basic principle:
advertising should be intelligible to consumers as advertising.  Business Guide on Native Advertising—applies to
commercial speech; has examples of what is/isn’t commercial speech, as well as
commercial speech that nonetheless doesn’t require disclosures (b/c it’s
obviously advertising or it’s not material that it’s advertising).  Example: paid ad “20 Most Beautiful Places to
Vacation,” by shoe company—b/c has nothing to do w/company’s products, and is
just a branding exercise, this wouldn’t be commercial speech that needed to be
identified as such.  Of course it would
be presented by the company/have their logo—the company wants to be associated
w/it, but doesn’t need to have the label as far as the FTC is concerned.  Journalistic ethics will also dictate
disclosures, but FTC wasn’t going to intervene.
 
Likewise, when an ad
is obviously an ad (shoe promotion w/slogan on a financial news website) it
doesn’t need extra disclosures.
 
Video game virtual
world: We assume video games are fully protected.  Consumers will understand in-game billboards
as ads. To the extent that the ads are for actual products, consumers will
attribute them to sponsoring advertisers and no separate disclosure is required,
but sponsoring advertisers would be liable for any deceptive product claims.  Advertising content w/in nonadvertising
content.  (As I said, like ads
interleaved in the pages of a print magazine.) 
What if they aren’t billboards in the game, but products are quests that
you have to interact w/?  If the game
conveys no objective claims about the products, that doesn’t require disclosure
b/c whether it’s paid placement or video game artist’s artistic judgment is
unlikely to be material to consumers. 
Simple product placement is commercial speech, but doesn’t need to be
labeled as such b/c its commercial nature is not material to consumers.
 
Deirdre Sullivan,
The New York Times Company: If it comes from our creative agency studio, we
disclose it.  Our disclosure has been
iterated, and highly negotiated down to saturation of blue, and serifs on
font.  We’re trying to create enough
distinction.  Cole Haan paid post: CH
doesn’t make ballet shoes; post was about dancers and their relationship to
their shoes; we make clear it’s sponsored content, though we don’t use the word
“ad”; business decision as much as a regulatory one.  We make no material claims, just interviews
w/ballet dancers, so there’s a good argument we wouldn’t need to label by FTC
standards.  Our subscriptions can’t
decline b/c of our ad choices—need to keep both constituents happy. Journalists
protect core of our product and keep subscription revenue up.  Newsroom felt that to do that we needed clear
language at the bottom of every paid post.
 
Q: did they execute
model releases?
 
Sullivan: Yep.  It’s a huge deal, and related to labeling
everything that comes out of the studio. 
Every paid post shouldn’t come to me; as a matter of course, all of our
journalists—studio is populated by folks from editorial background—go through
painful learning process about rights of publicity in their new profession.
 
Q: does that chill
content production?
 
Sullivan:
advertisers take care of some of that; most brands aren’t interested in coming
close to controversial subject matters. Some advocacy groups are more
interested in coming close.
 
Allison Lucas,
BuzzFeed, General Counsel: Similar approach. Almost everything we do falls into
the no material claims category, but we do put disclosures on everything b/c of
journalistic ethics and b/c brands want to say they’re doing it.  Publishers do a lot of mobile; can also talk
about social media and other platforms. 
Home page: we use “promoted by.” 
Story page: we put “brand publisher” for stories—brand had input into
it.  If it were commercial speech, that
might not be adequate for the FTC, but the content has nothing to do
w/Shutterfly, it’s just what children say they want to give their fathers for
Father’s Day.
 
Q: has FTC
considered requiring disclosure when consideration is paid, like FCC does?
 
Engle: No, we don’t
use that standard. We did take action against ADT when they hired spokespeople
to promote a new security system on Today
etc. and didn’t disclose they were working for ADT. That’s stealth advertising
that should have been disclosed; FCC didn’t take action [presumably b/c the
stations weren’t getting paid].  Even
when you see the “promotional consideration provided” disclosure squished and fast
in the end credits, we wouldn’t consider that adequate disclosure.
 
Almost all TV shows
for kids are effectively selling the characters; doesn’t want to go there.
 
Piety: what are the
reasons for doing native advertising? This has implications for whether
disclosure works. Ad Age asked: why would advertisers want to mimic content
when that’s so labor intensive and expensive and others can do it better?
 
Lucas: Clickthrough
is just infinitely higher.  B/c people
actually want to read and share it. 
Buzzfeed never did banner ads.
 
Sullivan: ads are
dying b/c of distraction, resistance, mobile; native advertising is a
lucrative, thoughtful way to do it. 
Advertisers like it b/c it resonates. 
One advertiser didn’t want it to be off the table for an advertiser to
win a Pulitzer.  Brand is just trying to
tell you something about who they are. 
Many advertisers have content studios in-house.
 
Piety: if you have
to disclose it, it’s partly b/c the concern about low levels of credibility for
advertising.  Maybe people don’t care so
much about Orange is the New Black, but for Scientology sponsoring they
do.  If skepticism increases, that’s a
problem.
 
Sullivan:
absolutely: there’s an integrity you think you can rely on from the NYT, and we
have to be up front about the ad content—we think it’s good, but you should
know its origin. Business decision as much as anything.
 
Q: does FTC’s
content-sensitive approach reconcile w/Sorrell
and Reed and right of publicity case
law?
 
Rick Kurnit,
Frankfurt Kurnit Klein + Selz PC: Maybe the message here is that the greatest
chilling effect on free speech will be from ROP concerns. Those concerns come
from the mess that is the ROP and the absence of commercial speech analysis for
ROP.  That’s why I want to move away from
Bolger.  My favorite false advertising case: NYT v. Sullivan.  An ad taken out by a corp. for the purpose of
raising money.  Individual claimed that
the context of what was described sufficiently identified him, anticipating White v. Samsung.  Unfortunately for him, he cast his claim as
defamation rather than ROP. 
 
Sullivan was a commercial/paid media insertion. SCt understood that there was
no such thing as advertising.  SCt understood
that it needed to deal w/ ability of wealthy individuals to use tort law in
Southern states to drive hated news organizations out of business b/c they
hated them. Then the worst decision ever: Zacchini,
which opened the floodgates.  9th
Cir. then embarrassed itself in Hoffman
v. Capital Cities
. Bounced around the circuit courts in search for some
kind of coherence; Rogers v. Grimaldi
is probably the best.  Cts are still
trying to say that almost everything is commercial for ROP purposes.  Jordan
v. Jewel Food Stores
: idiotic for a court in 2014 to believe that there is
still something to the notion that this (or anything) is an “ad.”  The ad was a free page in the publication for
putting up racks to distribute Sports
Illustration
—not even a paid media insertion. “Ad” is created by SI +
Jewel.  [I don’t understand why he thinks
Rogers is good but there is no such
thing as an “ad.”  Maybe he means
artistic relevance should apply to everything, leaving zero space for a ROP
claim?  I could actually go for that.]
 
Gov’t regulation should
be of false or deceptive content material to a consumer purchasing
decision.  Commercial speech regulation
is dependent on deception. Fear that people would make bad decisions if given
truthful information is insufficient; shouldn’t use truthful info to define
something as advertising.  Reed suggests that gov’t shouldn’t be
regulating based on who the speaker is or what the nature of the speech is
advertising. [So, no FDA then?]  FTC
policy statement is all about protecting consumers against deception, and he
doesn’t think anyone will have a problem recognizing that this benefits all
commerce, including legit publications. 
One departure: FTC embraced the notion that it could regulate not just the
integrity of the content (brand influence, false claims) but also the publisher’s
effort to distinguish themselves by maintaining value of their curation; should
not have required disclosure for curation. 
Chilling effect of burdening speech bears on the question of whether FTC’s
effort to provide consumers w/ a heads-up is ok; agrees that people would like
to know more about the content, but it’s virtually impossible to give consumers
all the relevant info about the author and what their biases are. So it’s
always only partial information [and thus I take it disclosure is unjustified].  While it would be nice to know when the NYT
is not pure editorial speech, it never is.
 
If disclosure is
limited only to when there are claims about the product or service, then maybe
that’s ok.  Then all the brand content
doesn’t need to be labeled as ads.  Right
now, people are still using labels disfavored by FTC; hard to get clients to be
the first one to accept a change.  FTC
policy statement in support of requiring disclosure that they’re moving from
editorial to brands is defended based on the precedent of the misleading
door-opener. But a high-powered salesman in your living room is more deserving
of regulation than a click where you only see it’s advertising once you’ve landed
on the page.
 
Engle: what about a
spam email? CAN-SPAM says ad has to be labeled as such.
 
Kurnit: Consumers
like it, but questions whether it holds up to 1A scrutiny. Should not be
treated as ad even if topic/interest is related to brand if it doesn’t make
claims about the brand. Chasm between what consumers are engaged w/online—celebrities,
excitement, Gawker—and what you do in advertising; this runs a risk of driving
the good players out of business and leaving us w/just the Darknet where the
FTC can’t ID the source of content.
 
Q: what’s the gap
b/t your approach and Engle’s?
 
Kurnit: the labeling
that you’re about to click on a brand’s site. 
If that site is mix of editorial and selling, I shouldn’t have to warn
people away.  Right now, there’s a
disconnect that I don’t need to label the ad b/c it makes no claims but I do
need to label the website.
 
Engle: that’s a
misinterpretation.
 
Q: Reed?
 
Engle: Reed isn’t a commercial speech case; we’re
looking at Zauderer in commercial
speech.  You could question whether we’ve
made the right choice about what’s misleading; we’d have to defend that line,
but we do contend it’s misleading if it’s not identifiable as an ad.
 
Q: Reed is a billboard advertising case,
though. [Um.]
 
Engle: subsequent
cases have distinguished commercial speech. Can’t imagine SCt would overturn 40
years of doctrine w/o mentioning Central
Hudson
; even Sorrell says it isn’t
talking about false/misleading speech.
 
Q: Kurnit’s argument
that there’s no such thing as advertising is that paying for space isn’t enough
and that saying nice things about your brand isn’t enough (in an op-ed by the
head of Exxon), but it sure seems like the combination ought to be enough.
 
Kurnit: Speech by
someone with a motivation to influence you to purchase a product who is telling
you something about the product likely to influence consumer decision—that’s
the heart of commercial speech. But there’s trouble finding a simple label.
Efforts to make a bright line, particularly in Bolger (ad format), are not helpful.  Bolger
isn’t consistent w/NYT v. Sullivan which
made clear that ads are within the 1A—a holding that’s gone ignored. [That’s
b/c it’s a misdescription of the holding, which was that this issue ad, which was not commercial speech, was fully protected
by the 1A, not that all ads were.]  FTC wants you to say “ad” but that’s like a
mandated skull and crossbones; it’s a stay-away label.  FTC has told everyone that “presented by” and
“powered by” and “brought to you by” are ok for editorial, but the world [to
wit, advertisers] wants something between pure editorial and pure advertising,
where brands get more “engagement” with the content. 

from Blogger http://ift.tt/1S2JuGD

Posted in Uncategorized | Tagged , , | Leave a comment

The definition of commercial speech

Commercial
Speech:  The Definition Matters
Moderators:  Chris Beall, Levine Sullivan Koch &
Schulz LLP and Bruce Johnson, Davis Wright Tremaine LLP
 
Steven G. Brody,
Morgan, Lewis & Bockius LLP: We barely spoke about the definition of
commercial speech. Why?  Is it b/c Reed has left us in the dust?  Or is it something more than that?  Background: gov’t usually loses if the speech
is noncommercial, but if it’s commercial, courts are much more likely to allow
regulation.  Central Hudson has become tougher over time, but still has a lot of
leeway within it for judges to uphold restrictions.  Yet 40+ years since Va. Pharmacy, we still don’t know which communications fall within
commercial speech category and which are fully protected noncommercial speech.
 
Treated as
commercial: solicitation of employment on public speech; gripe websites;
itemization of tax on medical forms.
 
Noncommercial:
fortunetelling for a fee; advertising for a school; public ratings of corporate
debt.
 
Keeps lawyers
employed but doesn’t advance the rule of law. Focus on two inconsistent
definitions of commercial speech: Bolger & Va. Pharmacy.  SCt has vacillated, but relied more heavily on
the latter.  Va. Pharmacy: speech that
does no more than propose a commercial transaction. “No more than” test.  Say that it serves the underlying purpose of
the doctrine; receives less protection b/c inextricably tied to commercial
transactions. So it’s logical that it should extend only to proposals of
commercial transactions. Opponents say that’s too broad; advertisers can avoid
speech restrictions by including discussions of public policy or unrelated
images. Such ads “do more than” propose a transaction. 
 
Bolger: A message
may be considered commercial speech by asking (1) is it in the form of an ad;
(2) does it refer to specific product; (3) does speaker have economic
motivation?  One alone isn’t enough, but
a combination of the factors could be enough. Opponents argue that fundamental
1A values are risked by this definition. 
 
Two other
definitions of note: (1) Central Hudson itself defines commercial speech as
expression related solely to the economic interests of the speaker and its
audience.  Close cousin of “no more than”
test—keep an eye on it.  (2) Nike v.
Kasky, Cal. SCt definition: consider the speaker, the intended audience, and
the content of the message. Would include practically any statement of a
corporation about itself.
 
Joshua M. King, Chief
Legal Officer, Avvo, Inc.: Avvo was sued on launch, taking issue with profiles
of lawyers.  Argued that rating was
defamatory, and that the profiles were commercial speech, making us in
violation of unfair trade practices. Court concluded that profiles weren’t
commercial speech even though we had an economic motivation—akin to traditional
form of publishing. It’s something that keeps coming back.  Two class actions allege that profiles are
commercial speech violating attys’ publicity rights, b/c we’re monetizing
w/advertising.  Cuts to core of how media
works.  Commercial/noncommercial can be
the difference b/t dismissal on the pleadings and a long, expensive fight.
 
Most of lawyers who
use Avvo deal w/consumer issues, and are keenly aware of att’y advertising
regs.  Bar regulations are so far afield
from strict scrutiny!  Att’y ads were
mostly banned until 1977; begrudging acceptance of 1A right of att’ys to
advertise by state bars.  Many bar
regulators aren’t even willing to engage w/commercial speech doctrine, having mostly
kept pre-Bates rules (can’t give
someone something of value for a recommendation etc., except for paying
reasonable costs of advertising).  Bars
are struggling w/social media, new forms of advertising: an att’ys own
blog?  Pay per click ads?  Almost w/o exception, the bars don’t even pay
attn to 1A, just apply their own rules as conservatively as possible.  Unfortunate b/c this is not changing despite Sorrell and Reed etc.  Advisory opinions
from bars—Cal. is the only state that pays attn to 1A doctrine when coming up
with advisory opinions. Doesn’t slow down lawyers who are skirting ethics
anyway, but it does chill more cautious lawyers from engaging in social media
or writing for publication.
 
Denise Esposito,
Covington & Burling and Former Chief of Staff to the Commissioner of the
U.S. Food and Drug Administration (FDA): Food & drug lawyer.  Overall question: whether a regulatory
program can exist in the context of a 1A challenge if strict scrutiny applies
to food & drug law.  Implications for
tobacco, all medical products, and foods. 
FDA is charged w/premarket review, determining whether a drug is safe
and effective for intended use. Historically required 2 adequate clinical
trials; expensive and extensive. Labeling is approved, which is supposed to
explain what it means that the drug is safe & effective. Some believe that
if you apply strict scrutiny, there will be no FDA; any pharmaco can do a study
and say “my study shows it’s safe and effective.”  That raises the question: who is the arbiter
of good science?  A judge can use Daubert to keep science out of the
courtroom. FDA believes it’s the arbiter of safety and effectiveness.
 
Amarin case: off-label marketing.  FDA’s
position was that off-label marketing was evidence that you intended it to be
used for an off-label purpose, and thus mislabeling.  Caronia:
court disagreed.  Off-label marketing
restrictions have also been challenged: sending doctors reprints of studies
that discussed unapproved indication. 
FDA tried to change its policies, but Sorrell intervened; the FDA wasn’t paying much attention b/c it
looked like a data sales case. But then the SCt said unconditionally that pharma
ads were commercial speech subject to different levels of scrutiny depending on
what opinion you’re looking at.
 
At the end of the day,
if FDA can’t ban truthful and nonmisleading speech, what can it do? If it puts
a drug on the market, can it do any regulation of the advertising as long as
the company has evidence to back up its claim b/c FDA is no longer the arbiter
of what’s truthful and nonmisleading? FDA says: we’re still the arbiter;
proceed at your own risk. If we find your studies to be poorly designed/misleading
of doctor or patient, we can still ban your speech.
 
Caronia: DoJ decided to test pure ban on off-label statements. There were a
number of false statements as well; the rep said to doctors, on tape, “this
drug is safer than aspirin,” but it’s the date rape drug.  DoJ didn’t pursue those claims b/c it wanted
to test the waters on whether rep could say “we are studying the drug for X, Y,
Z (unapproved) and our studies suggest that it works.”
 
Amarin: A company that promotes fish oil, which has a very good safety
profile. The public health argument was a little weaker b/c drug was relatively
safe, and the evidence was strong. Amarin had approval for product for lowering
high triglycerides, and wanted next level of approval for mid-level
triglycerides. FDA wanted a supplemental application, and Amarin did an
adequate clinical trial whose design FDA approved, and the clinical endpoints
showed what they wanted. FDA denied approval based on subsequent science
suggesting there was no clinical benefits to lowering triglycerides in that
group of patients b/c it didn’t seem to affect cardiac events. But Amarin said:
we’re willing to say “FDA doesn’t agree w/us that this should be approved.” 
 
Amarin has threaded through the industry in unhealthy ways. Clients say “I’ve
read Amarin, I can say anything as long as I do a 10-person study.”  Instead: be tempered, esp. w/public health
interest. Live w/fact that advertising is commercial speech, but can’t say
whatever they want based on any study, even w/disclaimers; FDA can’t say “you
can’t say X until we review and approve.” All the action will be about what’s
misleading, even if not false.  Caronia
quote: sales rep says marketing is part of strategy to manipulate doctors. FDA
plays a role here.  DTC ads to consumers
are also a big deal, can be manipulated by complex data.
 
Rebecca Tushnet,
Professor of Law, Georgetown Law School: I’m one of the people Professor Redish
labeled pathological in the previous panel. 
Just note about the First Amendment as the new Lochner: the example Redish gave of a city that bars its parking
lot to cars with Trump bumper stickers is structurally identical to the FDCA
regime: you can sell anything you want, but if you say it’s for diagnosing/treating a medical condition, then the FDCA
has jurisdiction and you can’t sell it while making those representations.  You might think that the FDCA is better
justified, but the point is that it’s really easy to make modern economic
regulation look like speech regulation.
 
From my area,
advertising law: Ford sucks said by GM is regulated the same way as Ford is
great said by Ford.  And gov’t’s having a
viewpoint, even if it were anticapitalist (which I strongly doubt) doesn’t mean
that laws it enacts reflecting that viewpoint constitute viewpoint
discrimination for 1A purposes.  If you
want to call perjury laws and fraud laws viewpoint discrimination, you can do that—they do reflect the
government’s view that those lies are particularly bad, and they do penalize
speech that would be blameless if uttered on stage or to a spouse—but I think
that concept muddies viewpoint discrimination into meaninglessness.
 
My preferred
approach to commercial speech is that advocated by Justice Stevens: the
distinction is government’s regulation of commercial transactions in order to
protect the parties to the transaction should generally be treated like any
economic regulation, even if the regulation operates by way of speech. Consumer
Reports isn’t making the exact same speech as Hoover, and Hoover’s relationship
to the transaction makes an important difference just as lawyer-client
privilege makes an important difference to how one can and should regulate
speech between lawyers and clients.  That
means that the gov’t’s reason to
regulate is important, though it is often possible to identify a consumer
protection purpose for many regulations. 
Stevens’ perspective also helps us identify what is commercial speech:
when it is sufficiently associated with a relevant transaction.  
 
Notably, Kasky definition is for the purpose of applying false advertising laws. Full quote: (1)
Because the messages in question were directed (a) by a commercial speaker (b)
to a commercial audience,  (2) and
because they made (c) representations of fact (d) about the speaker’s own
business operations (e) for the purpose of promoting sales of its products,
(3) we conclude that
these messages are commercial speech (f) for purposes of applying state laws
barring false and misleading commercial messages.
 [Reed is
unsustainable: I too find it notable that Scalia’s own opinion listed as ok
some clearly content-based restrictions that he didn’t even bother to correct
in response to the concurrences pointing that out. I do agree that watering
down of strict scrutiny is one likely result, as well as invalidating very
desirable regulations—worst of both worlds.]
 
Outside the Supreme
Court, the distinction between commercial and noncommercial speech remains
vital on a day to day basis.  Lanham Act:
Critics v. competitors—commercial speech provides a dividing line b/t
defamation law and false advertising law, which is strict liability for very
good historical and theoretical reasons. 
Also need to warn media lawyers specifically, who think that Sorrell and Reed are great news: be careful what you wish for.  Worse w/o the doctrine: Second Circuit: can
infringe TM by content of expressive work; right of publicity cases—recent 9th
Circuit case applying Reed to strike down right of publicity as applied to
noncommercial works like movies, but what if you can’t make that distinction.
 
Q: Microsoft just
bought LinkedIn: how much do developments in social media bear on what’s
commercial speech.  E.g., what is a like
on Facebook—commercial speech?
 
Brody: Social media
is good b/c combines commercial and noncommercial speech. Buzz marketing,
stealth marketing, blogs—very hard to pull them apart. Inextricably intertwined
doctrine: 9th Cir. supports that.
 
King: We see a lot
of bar regulators who think any use of social media is subject to att’y
advertising rules: can do it, but you must retain copies for years, use
disclaimers, etc.  I always tell att’ys
that you shouldn’t be marketing on social media b/c people don’t want that. You
should just be having a conversation. 
Test is still maddeningly unclear.
 
Esposito: FDA’s world,
warning letters are one enforcement mechanism. 
Interesting social media warning letters, including Kim Kardashian’s
Instagram.  But when does she stop being
a paid spokesperson?  Social media: FDA
requires fair balance, which means you need to talk about risks as well as
benefits.
 
RT: Social media
offer new methods for manipulation: called “stealth” marketing for a reason—that’s
the advertiser’s own paternalistic assumption that though you would ignore
marketing if you knew it was marketing, you’ll be happy to receive the information
if you don’t know.  Another example: my
competitor has people posing on social media as disappointed customers.
 
Q: are video games
commercial speech?
 
Brody: No. Art/game.
 
RT: Right now, it
doesn’t matter for the ROP. FTC standard: if there’s a paid-for factual
representation by the seller, then substantiation required just for that; doesn’t
allow FTC to regulate any other aspect of the game.
 
Q: don’t assume that
all media lawyers welcome Reed.  Instead a consensus that a tight definition
of commercial speech from SCt would solve a lot of problems.
 
Beall: uncertainty
of what constitutes commercial speech allows collateral effects of either
watering down strict scrutiny or deterring speech.  Rogers v. Grimaldi rule depends on
commercial/noncommercial divide. The advertising of the expressive work can
then use name/likeness and is not actionable appropriation of celebrity name. The
problem is what is actually the commercial part of the speech?
 
Piety: guidelines on
native advertising?
 
Beall: Reed and questions of imposing gov’t
regulation on the basis of content is deeply problematic for FTC regulations;
FTC is all about regulating the content of commercial speech.
 
Esposito: Breyer’s Sorrell dissent discusses this: if you
have a regulatory system, it will “discriminate”
based on content & speaker. Definition is less important than pragmatics.
 
Brody: Reed goes toward enhanced commercial
speech protection, but Zauderer and
its progeny moves in another direction.
 
Johnson: Zauderer plays a role in FDA b/c of
compelled speech.
 
Esposito: FDA has
tried to force graphic warnings on tobacco label; doesn’t happen in drug world,
where companies often want tort protection by using disclaimers.
 
King: Lawyers love
disclaimers, even though people don’t read them.  Bars love to come up with disclaimer
requirements and that’s under litigation now—they should only get reasonable
basis if necessary to cure deceptive speech, but other courts take position
that
 
Q: Derogatory
statements based on social network from competitor who pretends to be
dissatisfied consumer.  Why wouldn’t
defamation take care of that?
 
RT: B/c it might not
be defamatory.  “The technician was rude
and I felt uncomfortable”—even though that was totally false, falsity isn’t
enough unless it’s defamatory, under defamation law as opposed to false
advertising law.

from Blogger http://ift.tt/1tmtc73

Posted in Uncategorized | Tagged , , , | Leave a comment

The commercial/noncommercial boundary

The Shifting
Boundaries Between Commercial & Non-Commercial Speech
Moderator:  Vince Blasi, Corliss Lamont Professor of
Civil Liberties, Columbia Law School
 
Tamara Piety,
Phyllis Hurley Frey Professor of Law, University of Tulsa College of Law: Book,
Brandishing the First Amendment. 
Different origin stories, one presented by Kozinski and Banner (minority
position)—that origin story is that commercial speech was always protected, then
unaccountably removed in 1942, the Valentine
case involving a flyer advertising a submarine tour.  The more common understanding of where the doctrine
came from was 1976 decision in Va.
Pharmacy
, price advertising for pharmaceuticals.  Wasn’t really clear from Va. Pharmacy or Central
Hudson
etc. what commercial speech was—a bit of “I know it when I see it.” Belotti, not a commercial speech case,
asked whether corporations had speech rights, but Ct instead asked whether this
was the type of speech that’s traditionally been protected: answer there was
yes.  That characterization of
corporation as valuable speaker and of listener’s interests in receiving the
speech regardless of source came back to commercial speech.
 
Va. Pharmacy did something interesting w/truth, fleshed
out by Central Hudson.  Lawful, truthful, nonmisleading—then it got
relatively strong protection, requiring substantial gov’t interest advanced by
regulation, w/o unreasonable interference w/1A rights. Truth, then, is what
gives commercial speech coverage.  But
truth is precisely what we worry about the gov’t testing in the political
sphere!
 
However, SCt is interpreting
this test as closer to strict scrutiny than intermediate scrutiny over time.
Compared to rational basis, the obverse of strict scrutiny, for economic
regulation.  We’ve also seen articulation
of content neutrality and idea of speaker discrimination in commercial speech
context in ways that give rise to Qs about whether or not this is a distinctive
area.  If so, then the regulatory state
like the FDA and FTC are broadly under threat. 
One example: Daubert
distinguishes between types of testimony that are allowed; is that gov’t
discrimination based on the content of speech? 
Securities regulation, campaign finance, professional speech of doctors,
occupational licensing.
 
Martin Redish, Louis
and Harriet Ancel Professor of Law and Public Policy, Northwestern University
School of Law: Underlying theory of commercial speech protection. Describing
his own scholarly saga.   He invented
constitutional protection for commercial speech.  His first article was the first article to
suggest that commercial speech deserved significant constitutional protection;
not well received at Harvard where he wrote it! 
Began using as a foil Meiklejohn, whose 1A theory protected only
political speech. Premise: important actor under the 1A is not the speaker but
the listener, exercising self-gov’t, who needs info/opinions to make
self-governing choices. Redish said: let me stipulate to that for purposes of
argument; commercial speech then facilitates self-government, not in collective
sense where individual just has one vote, but in private self-gov’t sense where
individual has 100% control of his/her life—what car to buy, what house to buy,
what TV to buy—all central to self-realization. 
[Of course, the individual doesn’t have 100% control over any of these;
she is hostage to what’s on the market, unless she has the power of eminent
domain.]
 
SCt then defined commercial
speech as proposing a commercial transaction—Ralph Nader gets full 1A
protection for criticizing the Corvair, but Chevy doesn’t get protection when
responding (pre-Va. Pharmacy).  One side of a debate gets protection, the
other doesn’t.  Consumer Reports gets full 1A protection for saying Hoover is the
best vacuum, but when Hoover quotes that it doesn’t b/c they’re proposing a
commercial transaction—exact same speech to exact same people, burdened
separately b/c of speaker’s motivation. In no other area of law does speaker’s
self-interest reduce 1A protection.  Anti-tax
groups argue against taxes = self-interest. Unions pushing increased tariffs =
personal self-interest. Civil rights protestors = self-interest. You may like
that self-interest and not commercial self-interest, but that’s not an
appropriate basis of distinction. To reduce protection is to insert
anti-capitalist undertone to the 1A.  [Or
it’s about regulating commercial transactions.]
 
Rehnquist didn’t
like any free speech protection, so I disqualify him from consideration.  [Blasi asks: isn’t that disqualifying him
based on motivation.]  The number of
scholars who want to give no protection to commercial speech while protecting
others is Twilight Zone viewpoint regulation—drawing an exception for no reason
other than that you don’t like the promotion of that thing.  Steve Shiffrin’s response: kids today are thinking
about nothing but materialism; these aren’t the values we should instill.  Proves Redish’s point. It’s not b/c
commercial speech isn’t as valuable, it’s b/c they don’t like the message being
sent. Serious pathology. Irony: SCt in Sorrell
recognized that: otherwise unjustified distinctions in regulating speakers is
invidious viewpoint regulation, but hasn’t realized that, by that standard,
commercial speech doctrine violates the 1A.
 
Floyd Abrams,
Partner, Cahill Gordon & Reindel LLP: Two big cases: until 2011, whatever
else the SCt was saying was that commercial speech was different, and to be
treated differently.  Moved in Sorrell to unified treatment.  Heightened scrutiny, referring to consumer’s likely
greater interest in commercial information than in politics.  Dissent said: this means everything commercial
gets heightened scrutiny, which we’ve never done before.  FDA’s regulation of promotion of off-label
uses, for example.
 
Unclear how far the
Court had gone, and remains unclear; Court hasn’t taken a commercial speech
case since then, though it has had Reed
v. City of Gilbert
. Majority: says that any content discrimination triggers
strict scrutiny, citing among other things Sorrell,
which would indicate end of commercial speech doctrine; Breyer’s concurrence
objected strongly to that.  Question
remaining: did they mean it?  SEC, FEC,
it’s all content regulation—speech about airplanes!  More likely: strict scrutiny would be watered
down to sustain the regulatory state.  In
the securities area, he thinks that when stockholder votes on management, b/c
of Reed, it’s much more likely than
ever before that normal 1A rules will be applied, but will they be applied
literally?  Last week, 3d Cir. used the
phrase “drastically rewritten” 1A jurisprudence, reversing itself and holding a
statute unconstitutional w/r/t porn regulations. 7th Cir. and 1st
also reversed themselves in cases about bars on panhandling.  W/o proof that there’d been panhandling in
garages, couldn’t ban panhandling in garages.
 
Blasi: Scalia was at
pains to call himself a textualist. 
Should we think about commercial speech any differently b/c it says “Congress
shall make no law abridging the freedom
of speech
,” rather than “speech”?
 
Piety: that’s also
an argument for a more robust press clause, which has been subsumed into
speech. Not sure how this cuts b/c she thinks we don’t want to destabilize an
entire edifice of criminal law, libel law. Can’t take it so literally as to
mean “any speech.”  But that then takes
us back to Scalia’s resort to original meaning. 
What was the Framers’ idea of “freedom of speech”?
 
Abrams: Scalia said “the”
was the key word: takes us back to English law before the adoption of the Bill
of Rights, contrary to what Justice Black and others said, which was that the
whole purpose of the Bill of Rights was to escape from/move ahead of the old
England.
 
Redish: the most
textualism can do for you is fight back against the idea that there was
absolute protection for speech, which is infeasible.  “The freedom” doesn’t say you can never
regulate speech, if you have a compelling interest.  Beyond that, textualism doesn’t tell you very
much, and nothing about commercial speech. 
If it did, it would be that there’s no rational basis for distinguishing
b/t commercial and noncommercial speech.
 
Piety: one canon of
construction: you should not interpret a statute so that some part is
surplusage. There’s also a commerce clause. 
When we talk about freedom of speech, we seem to have moved into a back
and forth b/t theoretical, descriptive assessment and a legal assessment that
departs from full descriptiveness. It’s true that, in gay marriage for example,
there’s an expressive aspect to running a business.  But that may not be a very good principle to
apply to the regulation of commerce if we are to regulate commerce at all. If
all businesses are expressive then it seems like what you have is a 1A that
swallows the Commerce Clause. And New Deal aside, we are talking about putting
a constitutional cloud on an enormous number of statutes; that seems
ill-advised. Reed has created
doctrinal uncertainty.
 
Redish: Straw man;
you can use O’Brien to separate
expressive from nonexpressive. Your belief that African-Americans shouldn’t eat
in your restaurant doesn’t mean that you can keep African-Americans out.
Operating the business itself is not the same as speech, which is why the Lochner analogy breaks down.  Vitally important to separate them out—regulating
activity b/c of its communicative value and regulating b/c of its
noncommunicative harms.
 
Abrams: we don’t
advance the ball by reading “speech” in a way so broad as to include every use
of words. Perjury is speech. Spying is speech. [Or at least data
collection.]  There are words that all
agree are categorically excepted out of “the freedom of speech” because we’ve
always done it and the Framers must have meant that. We do need a bit of theory
here.
 
Blasi: Redish has
developed a very sophisticated and creative argument that many regulations of
commercial advertising have an element of viewpoint discrimination.  What’s motivating the regulation is an
ideological position.  Sorrell can be narrowly read to be about
viewpoint discrimination: Vermont was taking a position on generic drugs and
the like.  What Reed does is to conflate viewpoint regulation w/content-sensitive
regulation. There was no viewpoint discrimination in Reed. 
 
I’ll go further:
there’s not a judge I respect more than Kagan or a lawyer more than Abrams;
both agree that Reed’s law didn’t pass the laugh test, but he disagrees. Those
regulations were about duration and size of signs. The rationale for the
distinctions was that signs directing people to a location don’t have to be
big, and the smaller the better for clutter/aesthetics, b/c the potential
audience is looking for them.  Political
signs don’t need to stay up after election. For nonpolitical ideological
self-expression, that’s the strongest case for thinking the sign needs to be
both big and lasting. So that reflected sensible distinctions about which
speech needs which freedoms.
 
Key: Reed treats content-sensitive regulation
as viewpoint-discrimination, which is why it has such big potential
implications.
 
Piety: selling
stuff: is viewpoint-neutral. Not all of us would agree that Sorrell is about viewpoint.  As for O’Brien:
where’s the speech in selling data?  Not
an apparent connection to speech; the connection is to later use in marketing.
Marketing as such is not a viewpoint, which goes back to her point about the Commerce
Clause. 
 
Abrams: everyone has
an economic interest in what they do or say on certain occasions.  Content-sensitive is a very soft, euphemistic
way of saying “content distinction” or content-based.  Often viewpoint rooted even if hard to prove,
and we don’t want to get into legislature’s motive.
 
Redish: if a city
passes an ordinance saying that cars w/Trump bumper stickers can’t park in the
city parking lot, parking spaces aren’t speech but that’s discrimination
against someone b/c of her speech. Data mining isn’t speech, but there’s
discrimination against speakers b/c of their views.  Viewpoint discrimination is not normally from
the regulator, but from the court.  If
the court defines commercial speech not by the substance of what’s being said but
solely the commercial/noncommercial motivation of the speaker, that’s hostility
to capitalist interest of trying to make money. 
Speech about commercial products = would be a content-based regulation.  Exact same speech to same audience but
differently regulated = covert viewpoint regulation.
 
Piety: note that
businesses are supposedly always seeking to increase their profits, even with
speech that doesn’t immediately seem to benefit it. But we need to think about
what the rules of the commercial game are—antifraud laws are an important
boundary; without this line b/t commercial and noncommercial, then you get Rehnquist’s
concern: corporations may become more involved in politics, and indeed that
happened.  Speech/act distinction is
problematic.
 
Redish:
overtheorized.
 
Q: City of Santa
Monica decided to accept only ads that proposed commercial transactions on its
buses.  Reason: precedent where
Arab-Israeli conflict got played out on side of buses.  Everything said in 2d panel was turned on its
head; I had to demonstrate that AIDSwalk was engaged in a commercial
transaction in order to advertiser.  Led
me to Kozinski’s viewpoint: overtheoreticalization leads us down bad roads.
 
Abrams: one of the
few areas where American law provides less protection than available elsewhere.
Canada ruled that buses could and were entitled to have political ads on them;
legislature couldn’t prevent it.
 
Q: Alito’s
concurrence in Reed wrote as if he
were speaking for most of the bench when it said the Court wouldn’t be wiping
out a whole series of regulations, including distinction b/t on-site signage
and on-site signage—isn’t that content-based? 
If that’s true, what happens without Scalia?
 
Abrams: Alito was
trying to minimize the impact of the majority. True that the example Alito uses
is inconsistent w/the holding.
 
Blasi: Lower courts
since Reed have often found no
content discrimination. If you’re going to make content discrimination so
crucial, then there will be a struggle about what really counts as such. So
far, the pattern of interpretation has had the greatest impact w/panhandling regulation.
 
Q: where will we/should
we get limiting principles from about what the 1A will apply to?  Redish is saying that some things like
employment discrimination are outside the scope of the 1A, but that’s not
self-evident.
 
Abrams: Although I
mock some of the Reed outrage, I also
think it can’t mean what it seems to say. Two vulnerable points: What counts as
content based?  What counts as strict
scrutiny?  Last Term, there was a strict
scrutiny case for judicial campaigning, where it was clear to Abrams that the
dissenters had the better of the argument that, based on prior opinions, strict
scrutiny hadn’t been satisfied.  Under
the challenged rule: As long as the judge doesn’t make the solicitation
herself, everything was ok—he’s skeptical of that. Court may be moving in
direction of making strict scrutiny less fatal. 
Not a complete upheaval of the regulatory state, but a number of
sensitive areas—campaigns for shareholder voting sound like election campaigns.  For that to be subjected to the rigor of SEC
regulation as it is now is dubious post-Reed,
but he doesn’t think that sec. 11 of the 1933 Act will fall (false statements,
even negligently made or good faith, create strict liability).
 
Blasi: Breyer
emphasizes, both in Sorrell and in Reed, the quantitative dimension. He
talks about regulatory state, but what about impact on 1A itself? Is the 1A a
commitment that can be cheapened by overuse, disconnected from historic
struggles and just commonly invoked? I see it every September; only in last 3-4
years have there been a flood of second-year students w/potential 1A notes, b/c
in their law firms all of a sudden they’re thinking more about the 1A than ever
before.  [I believe Blasi
may have written something about this
.]
 
Redish: I don’t
believe there’s a need to draw on historic struggles. There’s nothing special
about history.  Framers agreed that
blasphemy wasn’t protected; flagburning was never even thought about.  [Ah, levels of generality.] The constitution
evolves, as long as you’re not exceeding the outer limits of the text and have
a coherent account.
 
Piety: Evidence,
civil forfeiture—in both these areas, SCt precedent conflicts.  Her sense is that notwithstanding the
invitation in Reed, the Court will
continue trying to duck it. Worst case scenario: watering down strict scrutiny
in areas we really want strict scrutiny. 
 
Abrams: One of the
objections to protecting commercial speech was that it would cheapen the
1A.  Now one writes briefs in political
speech cases, hoping to get as much protection.
 
Redish: Blasi has
argued the pathological perspective before. Question-begging: if commercial
speech is really fostering the same values, then it should get the same
protection. So we’re back to defining value. Also, there’s a danger of reverse
dilution, given pathology of regulation of truthful speech based on
paternalistic notion that people can’t decide for themselves; gov’t has to
intervene to make choices for them. If we accept that basic rationale, it should
apply to politics. If people are sheep, they are sheep. [This actually doesn’t
track with what we know about consumers as consumers—they’re vulnerable in
certain contexts, and not in others; it’s perfectly possible to be a sheep as
to topic X and a scholar as to topic Y. 
And as a matter of prophylactic constitutional law, deciding that the
gov’t is really bad in ruling in its own direct favor seems quite reasonable.]
 
Piety: we often want
gov’t to make our lives easier. Trial and error isn’t great for what’s
poisonous.  The paternalism argument is
often when the consumer is saying “I don’t want to receive robocalls” and goes
to the gov’t and the gov’t creates the Do Not Call list.  Response: if you knew what was good for you,
you’d receive these messages.  Same
argument was made in Sorrell. Yet we
know that the cognitive load from a deluge of messages is a big deal.  Rational response may be to ask the gov’t to
help you implement your own choice.  It
may be that we distrust the gov’t most in the political sphere. 
 
Redish: If you
understand public choice, that’s wrong.

from Blogger http://ift.tt/1sC9LqX

Posted in Uncategorized | Tagged , , | Leave a comment

Judge Alex Kozinski likes free speech and Lochner

Commercial Speech
Conference, Abrams Institute
 
Interview: Who’s
Afraid of Commercial Speech? — 26 Years Later
 
Ron Collins (Harold
S. Shefelman Scholar, University of Washington, School of Law) & Judge Alex
Kozinski (U.S. Court of Appeals for the Ninth Circuit). (Both, incidentally,
won their episodes of The Dating Game.)
 
Collins: Skelly
Wright said commercial speech doesn’t directly communicate ideas and thus isn’t
at the core of the First Amendment.
 
Kozinski: clearly it
does communicate ideas.  As a clerk,
watched the argument in Bates lawyer advertising case.  The idea that ideas belong in one
intellectual realm and commerce in a different realm is discredited.
 
Collins: does the 1A
have a central purpose as such?
 
Kozinski: clearly
not, if you mean the 1A as a whole. 
Speech/press/assembly: never thought of it that way.  Probably, an idea like the 2A’s: a way to
protect against gov’t overreach.  A
popular check on what gov’t can do.
 
Collins: what is
commercial speech?
 
Kozinski: A
noncategory.  Valentine case: strike it
from the lexicon. Doesn’t make sense to have a hierarchy, both theoretically
and practically.
 
Collins: You’ve
criticized theory-based approaches.  So
one theory is that speech is more protected the more it furthers democratic
self-governance.
 
Kozinski: Bull.  Society is not compartmentalized between gov’t
and other endeavors. Speech is speech, just as a functional matter. You get
ideas and they feed into popular culture, which leads to changes in gov’t.  Example: article
on criminal law I wrote in Geo. L.J.
, including on forensic science used by
prosecutors.  State of science in
criminal cases is a shambles. Basically voodoo. 
As a result of writing this article, I was invited to be a member of a
presidential commission dealing w/forensic science.  My piece in academia then is part of the wave
of ideas that (hopefully) affects and is affected by gov’t.  After all, nobody but the occasional
prosecutor wants to convict the innocent. And some of that speech started in
purely scientific fields.
 
You can characterize
everything as democratic self-governance; it’s not that everything feeds into
governance, but what we do in gov’t has effects in real life.
 
Collins: Meiklejohn
had a theory of free speech; ran into difficulties when Harry Kalven asked him
about artistic expression, and he expanded his views to include art.  Is artistic expression, when done for
commercial purposes, is that self-realization, or self-governance, or something
else? I ask b/c these theories are the constructs by which speech is gauged as
protected or not. A talented artist who says she’s in it for the money: what is
that?
 
Kozinski: it’s
difficult and futile to characterize speech that way. Useless. Subjective
intent of artist: baring soul or trying to make a buck, doesn’t matter.  [I’d like to know why the question is being
asked: what regulation might stand or fall on the artist’s intent?]
 
Collins: you said reason
for lower protection for commercial speech was in history, not logic; view
echoed by Justice Thomas in 44 Liquormart.  So someone selling cars, and making claims
about those cars, should be treated the same way as speech in the political
arena by Mr. Trump?
 
Kozinski: depends on
what you mean and for what purposes.  When
there are commercial transactions, you can have fraud, civil liability and
criminal liability based on speech.  Blackmail,
securities transactions—those are possible, which should not be possible for
political speech.  As a matter of theory
they aren’t different.
 
Collins: but what
you just said indicates that political speech is more protected in your view
than commercial, b/c of how you treat false speech.
 
Kozinski: some
things have implications that allow for punishment, b/c of direct harm to
victims from speech itself; that’s a narrow category. [Directness doesn’t do the
job he thinks it does—remember caveat emptor and letting the market decide.]  Doesn’t mean that speech is less important.
 
Collins: current
constitutional status, in your view?
 
Kozinski: SCt takes
cases at the margin, not the center; doesn’t mean a test is bad, just that
sometimes all tests have difficult applications.
 
Collins: then can
bright line rules survive in any constitutional context?
 
Kozinski: they’d
better, b/c the alternative is “who’s the panel?”  At least tests give you some broad ability to
predict/advise clients.  In 90% of cases
overall, it doesn’t matter who the panel is. 
Need to give a rationale that’s capable of application in future cases;
that’s part of the appellate judge’s role. Having tests w/prongs channels this
thinking, channels att’n of future decisionmakers and gives some measure of
predictability.  The fact that
close/difficult cases are still uncertain doesn’t negate that principle or
prove that tests are useless.
 
Collins: one taboo
of our time is “Lochner.”  Linda
Greenhouse: the Court returns to the bygone era of Lochner by labeling econ. reg.
of business conduct as a restraint on free speech.  (Borrowed from Rehnquist dissent in Central Hudson.) Others have echoed that charge, criticizing the Roberts Court for
using 1A as a deregulatory tool.  Your thoughts?
 
Kozinski: Can’t
speak to Rehnquist, but he likes Lochner, so that’s ok with him.  He doesn’t see a problem w/that.  When you talk about regulation, you’re
talking about gov’t control. 1A as a way of controlling gov’t: regulatory state
is a reality.  Does more day to day
governing our conduct than actual legislation. 
Good thing to put another check on gov’t regulation.
 
Collins: What about
data as speech/algorithmic securities trading?
 
Kozinski: it surely
is a form of communication, becoming the dominant form.  Has 1A implications, but not prepared to say
to what extent.
 
Collins: we tend to
think of speech as person to person, but when computers are sending data to
each other, the result of which is a commercial transaction, do you think it’s
w/in the umbrella of 1A coverage (whether or not protected)?
 
Kozinski: Doesn’t
see why not.
 
Collins: TM and free
speech: any thoughts about how to approach such issues?
 
Kozinski: wrote an
article, Trademarks Unplugged, about how TMs get injected into culture; easiest
way to communicate may be to use TM as shorthand for communicating an idea.
Displace other ways of saying the same things; give up the right to control
such uses.
 
Collins: what about
offensive speech in a TM context?
 
Kozinski: won’t try
to decide the REDSKINS case. Hard to say in the abstract; depends on the Q. If
Q is whether you want to make a reference to the TM in communication, that’s
different from whether TM owner is entitled to a particular mark that’s
offensive.
 
Collins: off-label
promotion by pharma cos?
 
Kozinski: Possible
fraud issue. 
 
Collins: if
truthful?
 
Kozinski: full
answer: claim that it’s truthful is beginning of inquiry. Might be truthful but
misleading, particularly w/things that are highly regulated like drugs. Ability
to mislead or create harmful effects w/truth is pretty high.  Concurrence in Alvarez: not a big believer in truth as a talisman; lying is part
of life. Distinction b/t truth and lying is not that useful in the 1A context.
 
Collins: porn is a
$97 billion global industry.  Some men
are convinced that porn sabotaged their sexual responses.  What sort of considerations would come into
play if a gov’t tried to regulate porn on public health grounds? 
 
Kozinski: can be
asked about other kinds of speech, such as Stevens
(crush videos) and violent video games. 
Had some doubts, similar to those of Alito’s dissent in Brown. Part of the problem is that Cal. didn’t
do particularly thorough job of documenting link b/t violent video games and
bad effect, but if there were really good, reliable research on a type of
speech doing harm, particularly to minors, gov’t should have ability to
restrict it.  For adults, that’s a more
difficult question; probably not, but trouble coming up w/principled reason.

from Blogger http://ift.tt/1Uvsmvh

Posted in Uncategorized | Tagged , , | Leave a comment

One reason the DMCA is no substitute for anti-harassment policies

Another reason the DMCA is not a good
anti-harassment tool
: it
requires contact information, which is sent to the party posting the challenged
content.

from Blogger http://ift.tt/1UL5jyU

Posted in Uncategorized | Tagged , , | Leave a comment

TM Scholars’ roundtable, part 6

Research Directions
Discussants:  Laura Heymann: What is the end of empirical
work? Which of our legal principles are based on assumptions or are not meant
to be connected to the Q of how consumers actually behave?  Lots of research about design remains to be
done: what aspects of design are performing the various functions we care
about, etc. 
Are there additional
costs from having trade dress protection that don’t already arise from design
protection?  V. versa.  Damages questions: if we are to have
apportionment, how shall it be done? What motivates consumers w/r/t specific
features versus entire collection of features/general reputation?
Aesthetic
functionality came up a lot.  Figuring
out how to parcel out the issues that are now grouped under that umbrella. 
Unfair competition:
relates to question of remedies. 
Graeme Dinwoodie:
Private practice/private ordering: uncovering what’s there. We might be in a
pretty good position to exploit that.
Empiricism is
fashionable, but it’s hard to engage w/that legally w/o a normative structure;
we often gloss over normative foundations b/c we think we know them but they’re
often quite contested, especially when it comes to remedies.  European remedies also deserve reexamination.  Often taught last in a rush even though they
may be the most important part of the case.
Lemley: A lot of
theoretical justifications for TM, and for defenses/limitation, are or ought to
be essentially resistant to evidence. We might want to know what people think
when they see a can of Coke appear in a movie. Almost all his students think
there’s a sponsorship relationship, but should that inform TM law?
Bone: Empirical
results are often a mess. We as scholars may take it to extremes: pick studies
that support us, or review a lot of studies but ignore their methodological
limitations.  Sounds a note of caution.  If you’re uncertain, do you default to
current rules? Reform nonetheless?
McKenna: think more
broadly about remedies and relation b/t TM and unfair competition, if remedies
are starting to divide more b/t technical TMs and others. There’s much history
to be mined.  Key structural difference
b/t technical TM and unfair competition was precisely remedies, so we should
reengage that project.
Dinwoodie: Echo Bone’s
skepticism re empirical work—additional knowledge can’t be harmful if we
understand what it does and doesn’t tell us. 
Also, empirical work is really good if you have a particular utilitarian
view of the world. Otherwise, you need other value systems.
Bone: not so much
utilitarian as consequentialist. 
Yen: we might be
horrified by what we found out about empirics.
Lemley: It doesn’t
follow that we don’t need the evidence, but we must think intelligently about
how to use that evidence. Even a nonconsequentialist would want to know the
impact of rules.
McGeveran: Empirics
doesn’t mean big data; Silbey’s qualitative work is empirical and interrogates
TM myths. Some may unravel tidy assumptions about consumer use of
info/autonomy. There’s also lots of myths that are used in normatively
undesirable ways. Take the bitter w/the sweet.
Dogan: we should see
who’s suing whom in product design: qualitative examination of cases; also the
registry.
Dinwoodie: CTM
regime may be clogged; companies are getting more sensitive to costs.
McKenna: more
evidence on clearance costs may be available. 
One woman he talked to advises clients not to change packages b/c
clearance costs are so extraordinary: need to clear TMs, designs across EC and
nationally. Interview studies about how people decide on packaging could be
very useful.
Lemley: A nominative
fair use doctrine for product configuration: communicating similarity but not
confusion.
McGeveran: would you
care if there were empirical evidence of confusion from certain nominative fair
use? I wouldn’t.
Bently: Basic
confusion level is pretty high—no matter what, some people will misattribute a
Visa ad to Mastercard.
Yen: Does that
confusion interfere w/the operation of the market?  It doesn’t seem to make people skeptical
about what they’re buying in stores.
Heymann: there are
always anecdotes of people who accidentally buy the house brand in the CVS.
[Discussion about
search attributes and the complexity of search; plus consumers may well just
have general impressions when they go to the store.]
Dogan: how would you
fix secondary meaning??
McKenna: there’s no
good standard even for word marks. We assume that, if people say, “I think they
make it b/c of that word,” there’s secondary meaning and move on.  W/design, consumers can assume that but also
not be using the design as an indicator of source.   Length
& manner of use, advertising etc. don’t answer the question, just tell you
people are familiar with the thing—not how they interpret it. Same is true for
word marks, but we’re more willing to assume that long exposure to word = treat
it as a TM.  If we actually try to do it
right, it will be so hard that we will rarely succeed/it will be very
expensive.  Litigation surveys
particularly.
Bently: accept that
there are many myths around TM.  People
think the largest word on a product must be the TM. 

McKenna: Tom Lee’s
study shows it doesn’t matter what the word is [unless it’s generic];
majorities think it’s the brand if it’s presented in a certain way on the
package.  This is to say that we really
say a term is descriptive when it would be too costly to prevent other people
from using it.

from Blogger http://ift.tt/1UHmbUG

Posted in Uncategorized | Tagged , , , | Leave a comment

TM/advertising question of the day, sexism edition

This ad sparked a fair amount of outrage in the UK, especially when Protein World doubled down on its insistence that only certain bodies should be seen at the beach:

“Are you beach body ready?” Protein WOrld weight loss ad

Dove responded with this ad:

Discuss.

from Blogger http://ift.tt/1OgyMS9

Posted in Uncategorized | Tagged , | Leave a comment

TM Scholars’ roundtable, part 5

Session 3: Remedies
In recent years,
trademark scholarship has focused largely on questions of subject matter and
scope, including much critical assessment of standards for infringement and dilution.  In this brief discussion, we will turn our
attention to remedies, and will consider whether creative approaches to
remedies might offer alternative means for reining in trademark law’s perceived
excesses, and/or for balancing competing interests in trademark disputes.  To this end, we will consider some of the
following questions:  What impact has the
Supreme Court’s eBay opinion had (and what impact should it have) on the
availability of injunctive relief in trademark suits?  Is it true, as many courts have held, that
the risk of permanent harm from infringement makes trademarks different from
other forms of intellectual property? 
Does it make sense to allow courts to grant limited injunctive relief
when they perceive a strong risk of confusion from a defendant’s use of a
symbol that indicates source, but has no trademark protection because of
functionality, genericism, or some other exclusionary rule (cf. Blinded
Veterans, Thermos, Singer)?  How
do/should courts measure damages in trademark cases, and how does it compare to
the approach in different areas of IP litigation (cf. the approach for design
patents)?
Introduction:  Mark Lemley: All the circuits that have ruled
on the issue have said eBay applies
to TM, so that we are to apply the four part test for injunctions preliminary
and permanent.  I don’t disagree w/idea
that eBay should apply but have
substantial concerns w/applications, particularly in 9th Cir.
Doctrinal error: they’re more guidelines to be balanced than elements to be
satisfied.  In the course of dismantling
presumption of irreparable injury, they then bar injunctions w/o such
proof.  That’s not what eBay thought it was doing. Also
problematic in TM sense; it’s hard to prove irreparable injury in a large array
of TM cases once you take away likely consumer confusion as evidence of
irreparable injury.  Evidence of actual
sales diversion = is it reparable? 
Factor 2 is
indistinguishable from 1: adequacy of remedy at law. But unlike patent/©, where
if you win you will get damages, in TM it’s not just possible but relatively
common not to get damages. Sales diversion is usually required. Profits still,
in most circuits, require willful infringement. May be changing for a kind of
dumb reason, which is the enactment of §43(c), which has now been read as
intending retroactively to change the rule in regular infringement, since
willfulness is specifically required for dilution profits.  But in many circuits you still have to show
willfulness. Combination means that you can win your TM case and be entitled
neither to an injunction nor to damages or profits b/c defendant wasn’t willful
infringer.  We could have a conversation
about whether that’s ok, but it strikes him as problematic.  TM ought to have a different spin on public
interest: consumer confusion is bad. We should count that.
Injunctions ought
not be automatic, but more common than in the wake of eBay; ought to be tightened up in favor of the TM owner.
Can you use eBay as policy lever to push back
against TM overreaching—Sandy Rierson & Peter Karol have argued for doing
that.  Prove TM infringement that
actually injures you—back door into materiality; way of distinguishing between
classic claims for confusion about source/product and confusion as to
affiliation or sponsorship.
Rebecca Tushnet
The harm stories
accepted by courts to expand TM are at long last being challenged at the remedy
stage, because showing irreparable harm requires plaintiffs to explain why
their harm is special and not sufficiently measurable to be compensable in
money damages.  This isn’t ideal, in part
because of its patchy nationwide implementation, but it’s still a positive
development and may encourage courts to have greater skepticism about expansive
harm stories in the first place.  Unlike
Lemley, I think eBay makes sense applied to TM. 
Where he sees a wrong in the failure to balance harm to the public
against the irreparability of the harm, I see a threshold that challenges the
court to ask whether the public is really being harmed in the first place.  The cases where eBay poses a serious barrier
to injunctive relief are almost never classic direct substitution cases.
Irreparable/not
compensable: easy case of distinction, where D lacks money to pay otherwise
reparable harm. Note too that if the D continues in a case declining to grant
an injunction, it likely becomes a willful infringer. I wouldn’t counsel
someone to continue under those circumstances.
Let’s assume a court
does find likely consumer confusion, in a case where a symbol is unprotectable
under TM law as such—unregistrable under §32. 
Should the court grant limited injunctive relief?  I have to admit, I’m a skeptic.  Such cases are usually at the core of classic
unfair competition—that is, they involve the same goods or services, even
though in the case of territoriality issues there may not be direct competition
or a real possibility of substitution in the ordinary sense.
Why am I a
skeptic?  A consumer rationale and a
producer rationale.  Consumers: we know
that disclaimers rarely work unless they are very carefully done.  Consumer has to be motivated to perceive the
difference.  Maybe this is an area where
disclaimers could work, but I would want empirical evidence that this is
so.  There’s one study that’s not very
promising, involving Bayer versus Bayer AG, the German entity that is
separately owned; the disclaimer there just didn’t work, and in fact was
indistinguishable from a so-called “claimer,” a statement that the two entities
were in fact related.  Essentially, as
many critics of disclaimers say, we’d be imposing the disclaimer requirement to
make ourselves feel better about the fact that consumers are going to be
confused; we can then put the blame on them for not being perceptive
enough.  Only if you view unfair
competition law as also being about commercial morality, which independently
justifies certain constraints, does the disclaimer requirement have an obvious
warrant.
Which leads me to
problem #2, the producer side, and that’s of course the strike suit.  I am skeptical that the game is worth the
candle if the only acceptable output is a disclaimer requirement.  I am skeptical that threat letters will admit
that the only thing a plaintiff in such cases can legitimately seek is a
disclaimer. Of course, in many cases whether there is no TM protection will
itself be hotly contested, so the additional encouragement to overreach
provided by an unfair competition rule is not as big of a problem as it might
otherwise be.  Further: how often do
producers make generic products, or functional products, with no other branding
but their shape or name?  The makers of
competing thermoses used their own branding, for example. 
Territoriality is
probably the situation where the risks of abuse by potential defendants are
highest—Belmora does not have attractive facts in terms of Belmora’s initial
conduct—but I think false advertising rather than more amorphous unfair
competition might well be able to address that. 
I do think that space probably should be opened up between TM and unfair
competition, but I am unconvinced that this space should be created by having
unfair competition get bigger rather than by having TM get smaller.  I know I’m kind of a one-trick pony here, but
the better-defined requirements of false advertising, especially materiality,
should at least be taken into account in considering the possible scope of an
unfair competition remedy.  This would
also allow us to think about how reasonable consumers should behave, since the
reasonable consumer standard tends to be more demanding in the false
advertising space.  Can’t always have
your cake and eat it too.
Lemley: Willfulness
when you continue conduct after determined to be illegal—patent courts have
said you’re not a willful infringer even though you know you’re infringing a
valid patent; the rationale is that we’ve baked the question of whether we
should punish you into the standard for granting relief. Maybe that’s different
b/t patent and TM because patent involves treble damages if willfulness is
shown, or maybe 2nd Circuit “you don’t need willfulness” standard
becomes dominant.
RT: I do think that
there would be a patent/TM difference, but that’s fair.
Discussant: Bill McGeveran:
reenergizing the understanding of TM adjudication as an equitable job is a
benefit of applying eBay. Judges have
been ordered to be more flexible about their job in TM.  Maybe some intermediate remedies are
inadequate, but it’s worth learning more about them.
Willfulness/damages
is happening independently from different sources—courts are not consciously
reasoning that injunctions are harder to get so damages should be easier to
get, but maybe that’s opened ground for them to reconsider what the proper
balance should be.
Lemley: From TM
owner’s perspective, can trade things off, but as we move from injunctions to
damages we lose benefit to public. Not a fair tradeoff to say you can confuse
consumers by paying the P.
McGeveran: there are
both dials—some injunction, and some damages.
Kur: We have only
one ECJ decision about fines for disrespect of injunctions. Even if infringer
is clear that it will never happen again—infringer was victim of fraud—you have
to impose fines; no leeway for national course. 
Would also apply to injunction as such. 
We see an element of compulsory licensing here.  There is a difference b/t patents, designs,
and TM—no compulsory licenses in TM are allowed.  There is the public interest. 
Disclaimers: we need
research on how well that works.  There
must be cases where companies have the same name but are separate.  Budweiser: they don’t want to coexist but we
could think about making that easier.  It
shouldn’t just be continue infringing, but it should be some requirement or
there’s a risk of conflict w/international law.
Dogan: how does this
relate to yesterday’s conversation: is there something unique about product
design that might make it more suited to alternative remedies.
RT: compulsory
licensing: but that gets back to whether an interest has truly been
invaded.  TM harm stories (very different
in Europe) just aren’t that convincing.
European approach if
there is no mark, as w/genericity: can there be prohibitory injunction?
Kur: w/unfair
competition, there’s no common answer across EU. In Germany, it would be case
by case remedy; hopes it wouldn’t be pure prohibition on use of
generic/functional feature.  Wouldn’t run
up against bar on compulsory licenses b/c it is outside of TM.
Dinwoodie: normal
remedy for slavish copying is pure prohibition.
Kur: but might not
be the case if the feature were truly functional.
Lemley: similar
issue in patent/©: what if injunction reaches noninfringing conduct?  Fits into balance of hardships factor. If
injunction shuts down use of whole product including noninfringing pieces, that’s
a reason not to grant.
Dinwoodie: In
Denmark, Lego lacks a TM in the brick. Can they get relief against slavish
imitation?
Kur: speculative;
doesn’t think it has come up.
Dinwoodie: Slavish
imitation is about commercial ethics, not consumer understanding. The case law
under 43(a) in the US is the smidgen of consumer understanding—not enough to
bar us from saying it’s generic or functional. 
The relief under 43(a) is a lite version of consumer protection, but Continental
cases may be much more driven  by
commercial ethics. When we say unfair competition, these are two different
variants.
Grynberg:
Intermediate remedies may just not work. 
Not just a problem for generic/functional.  Also true for non-source confusion,
affiliation claims. Consider possible dynamic effect: if we just stopped
protecting trade dress, consumers might change; we should consider the possibility
of standardizing a disclaimer remedy, which might not work in the near term.
Peter Karol: Though
every circuit has applied eBay, there’s
a huge variance in what that means to them, amounting to a rejection: sometimes
they cite eBay but allow courts to
presume irreparable harm (11th Cir.), and say that the ordinary
remedy is injunction (district courts). 
Normatively: a lot of whether eBay
should apply relates to what you think it was doing. Most courts do think they
have flexibility, but rubber hits the road if you think that presumptions are
suspect.  Good reasons to distinguish
patent and TM for presumption. 
Presumption of injunction for infringement could be overcome by laches,
delay, balance of harms—that was consistent w/equity, which didn’t require
chucking presumptions.
W/r/t difficulty of
getting damages, that developed b/c of Champion
Spark Plug
& similar cases which said “injunction is ordinary, so
damages should be rare.”  We’re now so
distrustful of what TM is doing (or uncertain) that you might not get anything—that’s
a bad situation.
Bone: The equitable
factors are no mystery. The first two factors are threshold, and the balance of
harms is a balance.  I for one am glad to
see it introduced in more traditional way into IP.  Maybe should make eBay context-specific. For product design, I’m with Tushnet.  No presumptions, requires proof of
irreparable injury. False negative error costs are lower—denying an injunction
isn’t that bad b/c there are other marks to distinguish the item.  Willfulness: depends on reasons why you’re
denying injunction. If denied b/c no irreparable injury/no adequate remedy at
law, then continuing to do it could be characterized as willful. 
The problem
w/consumer harm is that you can’t pay them directly. But indirectly, you might
be able to affect that by requiring D to pay P in a way that might induce
change.
Dogan: especially
for affiliation confusion, if we believe that consumer harms are illusory or
minimal.  Materiality through the back
door.
Dinwoodie: In Europe
we don’t have a common view on unfair competition.  It is optional to apply the enforcement
directive to unfair competition. British debate at the moment: patent case on
injunctions indicated it was willing to go more eBay-like in private law cases, and patent judges have indicated
their attraction to that.  In continental
Europe, injunction comes automatically from violating property-law right; there
may not be harmonization, but proportionality and other rules in the enforcement
directive have enough give to create a range of remedial options.  Hollister case, TM context, has been an
effort to use proportionality to temper relief in TM cases, particularly
parallel import cases—repackaging where infringement was only due to technical
failure to give notice to a party.
Bently: Unused
registered mark—clear sense that it would be inappropriate to give injunction
where it was now being used by a large business. We will probably be flexible
unless ECJ tells us we can’t.  Enforcement
directive makes it a bit messy b/c says injunction shall be granted except in
special circumstances.
McKenna: There’s an
enormous amount of additional work to figure out the role of empiricism. I’m
sympathetic to the need to focus on whether harms are real. Law has decided not
to do that at wholesale level: whether sponsorship confusion is harmful, for example.
Retail level is second-best. In some ways, I’m with Tushnet to say that if we’re
raising the Q at the remedial stage, b/c we have doubts about fact of empirical
harm, it’s weird to impose remedies w/o empirical basis. Why go halfway on
empiricism?  OTOH, they’re operating at
different levels. We’re accepting a generic harm story.  Disclaimers might not work, but consumers do
adapt, so there may be other things courts can do.  But we have to identify the problem we are
trying to solve when we pick a remedy. A disclaimer doesn’t work if I’m trying
to disabuse consumers of certain notions; changes in packaging might work for
other purposes [e.g., Belmora maybe?]. 
We’re doing this w/presumptions built in a world of TM law we don’t live
in any more, from when confusion really meant passing off, now applied to
enormous range. But b/c we didn’t have a real conversation about harms of other
kinds of confusion, we have to do it in nonideal circumstances.  [“[Lawyers] make their own [law], but they do
not make it as they please; they do not make it under self-selected
circumstances, but under circumstances existing already, given and transmitted
from the past.”]
McGeveran: dynamism
is an important point.  Certain types of
disclaimers—consumers could learn.  [But
what is your reason for believing that?]
Presumptions are not
all created equal: rebuttable, bursting bubble, etc.  We have choices.
Remedial modesty has
different implications for different kinds of cases.  [This is maybe one more reason to identify
classes of cases, the way Pam Samuelson has for copyright, which affects both
the confusion tests/defenses but also the remedies.]  Public values exist on other side—first sale,
comparative advertising, consumer information interests, etc.  Peripheral confusion (endorsement etc.) +
clear values on the other side = good case for no injunction, as a matter of
standard civ pro thinking.
Lemley: why isn’t
the right response then “you’re not liable”?
McGeveran: that’s
the first best solution.  Second best
would be limiting doctrines. Third is remedies, but that’s something.  Tabari: lower court enjoined use of “Lexus”
in any circumstances, though Kozinski accepts some residual likelihood of
confusion on affiliation, and makes rules about how to tailor nominative fair
use injunctions.  Can get it out of
domain name in some circumstances, but not full ban.
McKenna: if you
flunk nominative fair use, the injunction can only order you back within its
bounds. 
RT: Bone’s
suggestion for eBay being stringently
applied to product design: seems plausible, but what about descriptive terms, where
there are also error costs issues—are we working back around to technical TMs?
Might be good w/that.  Grynberg: dynamic
consumer response is great, but the problem is that response to disclaimers decays over time, so the suggested
remedy has a mismatch with the ideal result. 
If the market responds, it probably won’t be b/c of the disclaimer but
b/c of independent consumer learning.  Package
redesign is not ordinary disclaimers so there is a lot to be learned about how
that might work.  Graphic design elements
might turn out to be really important.
Tabari is a really interesting example of empiricism: nominative fair use is
very explicitly about deciding that things are nonconfusing as a matter of law,
which is to say that it’s not empirical.
Kur: It would be
useful to have access to covenants that firms sign to prevent too much
collision in the market.  Our knowledge
about how one could do that as a remedy would be improved by such learning.
Heymann: consumer
research about how consumers are trained to look for particular
features/interact more with the product. 
That could help w/specificity and tailoring.  Though standardization also produces gains on
the consumer side (e.g., nutrition labels). 
Relatedly: what the goal is for these kinds of remedies.  We have a sense of what damages are supposed
to do.  But what do we want injunctions
to do? Where is the consumer in all this?
Bently: yesterday we
were expressing doubt that product design is relied on, but now we’re
suggesting it as a remedy?
RT: I understood
myself to suggest that color on packaging might be helpful, but I wasn’t
talking about the design of the product itself [though others think that might
also be worth investigating].
McKenna:
second-best; we might think product design is rarely relied on, but at the
remedy stage the court has rejected that. 
Also, even if there’s some source designation, it’s also doing other
things, and we might want those other things available while trying to do something
about the source designation that might not be a full fix but mitigates the
harm.
TM as info
transmission system; yet admitting that there are lots of things that have nothing
to do w/info and more to do w/equitable position of parties.
Bone: Effectiveness
of disclaimer has a lot to do about whether consumers care; if disclaimer doesn’t
work, it might be b/c consumers don’t care, and aren’t harmed.  Empirical work on disclaimers: our results
would have very high variance. Some rely and some don’t. Depends on
context.  Sometimes they reduce confusion
somewhat; leaves normative question of how much reduction is worth the
candle/we will require to accept disclaimer.
Heymann: Product
liability, product warnings—the law doesn’t care much about whether they
actually work.
McGeveran: this isn’t
the only area where there’s existential angst over subjects’ reaction. Privacy
policies that no one reads.  He’s happy
with rules that make clear that the most you can require a Lexus dealer to say
is “we’re not affiliated w/Lexus.”
Yen: Costs imposed
on consumers should be considered. Injunctive remedies on D impose search costs
on consumers; the ones who learned to distinguish the brands and are happy—if you
take one brand away and make it be different from existing mark, consumers
incur search costs to find it (or to avoid it!).  If we’re interested in disclaimers, the
analogy to tort has to be careful. 
Warnings in tort are used in the context of fault.  Even though products liability is strict, the
Q is whether it’s reasonable to sell product w/ or w/o warning. If you sell
product w/reasonable warning and consumer gets hurt anyway that’s not your
problem. But TM is supposedly  not fault
based—if consumers are confused, you’re liable.
Burrell: enthusiasm
for highly fact specific injunctions was a little surprising. If you can’t predict
what injunction will look like, you’re less likely to reach settlement, which
is to be welcomed.  Similar issues exist
w/nuisance, where injunctions are delicately shaped.
Dogan: Think holistically
about ways of avoiding confusion, presale and point of sale; even highly fact
specific cases can start establishing norms allowing commercial practices to
evolve, shrinking the scope of product design trade dress. Wouldn’t require
that level of precision in every case.
McKenna:
historically unfair competition had to show intent; for technical TM we
presumed it b/c same mark/same goods. What happened? We lost sight of that.
Presumption of intent in technical TM made sense in same mark/same goods, but
doesn’t as applied to other things. 
Also, when test asks for reasonably prudent consumers, you’re asking a
normative question. So we’re willing to live with unreasonable confusion. So
analogy to tort is actually good.
Thinks that old
unfair competition cases aren’t about: this thing is functional but we’ll give
you some remedy. Rather, the cases are about: this thing is functional, but D
is making the problem of confusion worse when it doesn’t have to. It’s fault
based.  Not necessarily going to fix the
problem. But your entitlement to do X doesn’t mean you have to do Y, Z. Fault
based.
Bone: he sees an
affirmative obligation to take measures to limit confusion.
Dogan: sees
both.  The language of the courts is
affirmative obligation, but the facts show D doing something else besides using
the functional feature.

Yen: doesn’t think
that modern TM law today admits of fault as a doctrinal requirement.  We can read it in, but courts don’t say it.
If we talk about fault, we need to talk about intentional tort and
negligence.  Unreasonably incurring risk
of bad result is something courts haven’t worked out in TM.

from Blogger http://ift.tt/1tgMR8j

Posted in Uncategorized | Tagged , , , | Leave a comment

TM roundtable, part 4

From last time: RT:
I was thinking as Silbey was talking that you’re convincing me that TM should be a particular kind of
anticopying regime (though, as w/patent, knowledge need not be required, at
least for double identity).  And that
would argue for a greater role for registration, which I think is a desirable
outcome: it would be good to channel people into registration by making it hard
for them to win when they haven’t registered; I wrote a whole article
about that
.
 
Mid-Point
Discussants:  Robert Burrell: Using the
patent monopoly period to develop secondary meaning.  Concern over this led UK to have rules.  B/c British TM law at the time didn’t extend
to shapes, this concept was initially limited to words. Some Commonwealth countries
still have similar provisions: when product produced under patent, you can rely
on TM when you have secondary meaning; remain fully enforceable for up to 2 years
after patent expired, but then name becomes free to use.  Reflects understanding that markets can correct
and be corrected: you now have two years to rebrand your product. Australia
case: Main Indus. interpreted the current provision to apply to shapes as well.
A shape can describe a product.
 
Patents correct for
market failures. But when we take TM seriously, they have a more fundamental
effect in the establishment of a market. 
Hard to imagine a market economy if I were free to sell sugar pills as
Tylenol: more of a market-constituting effect than patents. If that’s right, it’s
not obvious why we’d prioritize patent logic over TM logic. Yet most of us
would immediately do that. B/c TM have become untethered from any rational
basis whatsoever. When we think about shape marks/trade dress, they’re almost
invariably limping TMs, with other things on the product we can use to ID
source. We don’t think that Pepsi has joined Coke when Pepsi uses a similar
bottle. Consumers can respond quite quickly when similar products emerge. Budweiser:
there are two sources, and consumers in the UK rely on other indicators of
source.  Traditional rules aren’t working
well. Distinctiveness test doesn’t work well applied to shapes, as McKenna
said.
 
Rights stacking:
another way of thinking about problems from TM perspective is precisely that it’s
almost never the case that a 3D TM works on its own.  Beebe/Fromer on running out of marks;
Australian Productivity Comm’n
doubts whether you should have more than one TM per product
, which he
thinks is extreme.  Design patents over
every little part of an object: consider accretion of rights through one system
and not just questions of channeling.
 
Michael Grynberg: Courts
are concerned for reward; other schemes might ensure that those concerns aren’t
being unmet. Why are courts so appreciative of utility patent’s ability to do
that and not design patent?  Prominence
of design patent is increasing, and this may sensitize judges to the possible
force/power of design patent.
 
Disclaimer practice
as a means of keeping fences; if you do that then you can copy.
 
Dinwoodie: what the
courts in UK have said about limping marks would invalidate a lot of
marks.  The Austl. Productivity Comm’n:
the impetus for this idea is plain packaging, b/c one of the arguments that
they made before the WTO is that you don’t need the logos b/c you still have
the words. Might be driven not by TM concerns but by other concerns.
 
Lemley: Design
patent seems a close, logical parallel to ©: trying to encourage creation of
nonfunctional thing. We do have functionality in © in various doctrines; so why
not look at that kinship.
 
Grynberg: The
existence of design patent should give TM pause about protecting the same thing—it’s
not kinship.
 
Lemley: then shouldn’t
© also give the same pause?
 
Grynberg: Fewer
cases involve that tension.  [Logo
infringements?  I’m not sure how many
noncounterfeiting real logo copying cases there are, as opposed to things like
stylized initials that probably don’t cross the © threshold.  Of course, TM lawyers are now telling clients
to use © claims to protect marks.]
 
Lemley: There are
fewer cases where courts take seriously that © ought to have some preemptive
power, except where the © has expired.
 
Dogan:
Distinctiveness protection is different from exclusivity designed to encourage
creation; so what is wrong with leveraging exclusivity for secondary meaning?
That is looking only at the values that justified creating the rights in the
first place, but other values inherent in the system as a whole call for
limitations. The reason we provide protection is to incentivize for the
ultimate benefit of the public; can’t lose sight of that value.
 
Kur: wants to use TM
principles informed by principle of undistorted competition—the existence of a
patent doesn’t mean there can’t be a TM; though she wants TM rights to be
narrow. Patent shouldn’t have automatic effect in another regime; it tells a
story about competitive needs, but it’s not an absolute argument. 
 
McKenna: for me that
doesn’t answer important questions: which kinds of competition, under what
circumstances? Can’t be derived from TM first principles. Some people are
resistant to the idea that things in the patent universe have preemptive effect
but are ok w/ expired utility patents having that effect. 
 
Kur: I don’t want to
say that all the different types of IP are unrelated to each other.  The more there is a need for using the shape,
the smaller is the scope you can grant a TM right: these are TM principles.
They help you use utility patents to figure out what rights should be granted.
TM is based on the assumption that TM is separate from what’s actually
protected and doesn’t hinder competition & the sign is in infinite supply;
the further you get from that, the more careful you have to be.  [I wonder to what extent this is really about
harm done by the fact that we have an incredibly lax
distinctiveness/distinctive character requirement.]
 
Bone: If TM did what
it was supposed to be doing and patent did too, we wouldn’t have a problem. But
we worry not just about whether TM is performing its functions but also the
effect of the practicing bar using these theories.  A good TM law can be deployed in ways that
interfere w/ policies in other areas, so we can’t silo them. Not as optimistic
as Kur seems to be that getting it right in the silos will suffice.
 
Peter Karol: Note
about timing: you see these claims when the patent expires b/c that’s when
competitors enter the market!  Will also
make 2018, when ©s begin to expire, an interesting moment.
 
Dogan: design patent
surge as direct response to SCt scaling back trade dress protection at the end
of the last century.  When those design
patents begin to expire that will be another interesting moment: more cases of
cumulation of rights than we’ve seen historically b/c of the greater volume.
Empirical question: will they invest in developing secondary meaning in these
designs?
 
McGeveran:
Coordination isn’t a matter of mere tidiness; need an independent reason to
police the boundary. Nothing wrong w/pursuing alternative legal theories of
recovery; it’s actually sometimes good. But the law does create boundary policing
mechanisms when a problem results from it, e.g., the economic loss doctrine.
Can’t end run around contracts by using tort when that undermines the actual
bargain.  Then there are exceptions to
the economic loss doctrine. Based not on borders for their own sake but for the
policy reasons we have those boxes/want people to stay within them.  If someone patented a real, Back to the
Future hoverboard, and they happen to shape it an arbitrary way, like a purple
hexagon, he’s comfortable w/saying “flying goes into the public domain, but not
shaping it like a purple hexagon.” Some of the commentary does not think
carefully enough about what an expired utility patent is evidence of.  [This point is very clear in Dinwoodie &
Janis’ TM casebook.]
 
McKenna: if you can’t
make an end run when you have an expired patent, it seems that you shouldn’t be
able to make an end run by declining to seek a patent either.
 
Silbey: patent as
evidence that it really did fit within that regime.
 
Lemley: we do feel
differently about McKenna’s point b/c of vestigial instinct that you got to
choose b/t regimes. 
 
Ornamentality might
justify further attention: if it’s not attractive, then it shouldn’t be part of
a design patent.
 
Silbey: if you shape
the utility patent to get around prior art to include the hexagon in the
hoverboard, it seems like you’re taking advantage of the patent system. But not
sure what expired design patent is evidence of that’s distinct from trade
dress. Does it have a quid pro quo the way we think of utility patents have?
 
Dinwoodie: not much
of a quid, because by selling the thing you’re disclosing its visual
experience.
 
Yen: Smells like
election of remedies.  You got an extra leg up in establishing
secondary meaning, that others don’t get.
 
Bone: but if the
system works, so what? If we think TM is double dipping, then sure, but if it’s
dealing w/harmful consumer confusion, we might say that developing secondary
meaning and communicating w/consumers is a good thing.  A question more of deployment than of
doctrine.
 
Yen: but to the
extent the thing we have a design patent for has some “useful” function, there
should be a potential limit on what TM would allow, here aesthetic, right?
 
Dogan: if I go to
market w/a chair, others can copy it before I have secondary meaning—but if I
have a design patent I can keep that from happening. Properly designed
aesthetic functionality test could figure out if people are demanding the chair
b/c of its aesthetic properties v. its popularity, but the test is not likely
to work well unless the expired design
patent is evidence of aesthetic functionality.
 
Dinwoodie: Children’s
chair case—the EU has started to develop a series of factors to figure out
whether something is iconic—taxicab case, J. Arnold discusses the role of
designs.  Dogan is asking for something
close to what they’re doing.
 
McKenna: meaningful
ornamentality requirement could allow us to say that presence of design patent
is evidence of non source related aesthetic value/function just as presence of
utility patent is evidence of non source related utilitarian functionality.

from Blogger http://ift.tt/1Ujj1KX

Posted in Uncategorized | Tagged , , , | Leave a comment

TM roundtable, part 3

Session 2:  The Menu of Options for Design
Protection:  Where Does/Should Trademark
and Unfair Competition Law Fit?
This session will
consider product-design trade dress protection in relation to other legal
regimes that encompass design (design patents, copyright, and sui generis
design laws).  To what extent is there
overlap between these regimes?  Is such
overlap desirable?  Costly?  Are channeling doctrines appropriate and/or
available to minimize these costs?  What
doctrines do these other regimes use to filter out designs that, for one reason
or another, are inappropriate for protection? 
What are the relative virtues of these doctrines, as compared with
trademark law’s functionality doctrine? 
Does the cheerleader case give us any insight on this question, with
respect to copyright’s useful article doctrine? 
What is the relationship between trademark functionality and trade dress
functionality, both on the merits and in terms of preclusive effect?  What are the costs and benefits of a sui
generis regime, either alongside or instead of trade dress protection?
 
Introduction:  Mark McKenna: Options: Utility patent, design
patent, copyright (Varsity Brands may indicate more protection for design than
others thought). Different defenses, duration, cost to acquire.  Different claiming mechanisms: words,
pictures; ex post, ex ante. Design patents involve a specification prior to
assertion against any particular defendant; stable understanding of what it is,
as opposed to most trade dress cases which involve claiming in litigation,
strategic.  [Burstein might say that
continuance and splitting practices allow some manipulation of design patents
along these lines.]  They don’t have to
be alternatives; increasingly the case that people use many at the same time,
often for the very same features.  Notice
issues.  Using design patent to get
secondary meaning, leveraging limited for potentially infinite protection. Competition
policy can be undone by such leveraging.
 
Two views of how to
think about overlaps: Ebbing and flowing over time in which predominates.  One is strong channeling sense that certain
subject matter belongs in different buckets. 
You don’t want one regime to undermine the placement of that stuff in
the right bucket (or not being allowed in the bucket). Strong view of Sears/Compco—keep TM out of the way of
patent.  This isn’t just about features
that were, or are, or could have been protected by patent, but about keeping it
out of patent space—keeping it away from patent law, not just from patents.
That which is excluded from patent law is excluded for a reason; meant to put
things into the public domain. Sears involves
utility and design patent; Compco is
just a design patent. This is about lack of protection for unpatented designs,
not functionality. Courts then started to think of those cases in preemption
terms, not policy terms.
 
Alternative view,
pre-Traffix: overlap is itself not
especially problematic; multiple systems exist but have different advantages
and disadvantages. Lack of patent doesn’t tell you much/anything about TM. Overlap
only becomes a problem in cases of real competitive need.  “Functionality” is defined as per Morton-Norwich.  A retail determination of need, rather than
wholesale. This is a significant challenge b/c the issue is precisely what market
you should be allowed to compete in. Need richer normative view of ok kinds of
competition.
 
This view is much
less concerned with overlap; patent protection is only one factor, often not
dispositive—6th Cir. in Traffix
itself reasoned that it wouldn’t cost much to use three springs or put it in a
box. Not connected to semantic meaning of functionality—have a function—unless you
assume that the only things that have competitive value are functional.  It’s really about competitive need; narrowing
Sears/Compco to utilitarian features
rather than the other aesthetic things they were dealing with.  Once you say this is just about competitive
need, it’s easy to say that there are lots of things for which there is
competitive need, so aesthetic functionality makes just as much sense as
utilitarian functionality. But the terminology now seems totally divorced from
original semantic meaning of terms.
 
Competitive need =
aesthetic functionality becomes unconcerned w/channeling away from design
patent. Away from categorical channeling of Sears/Compco.  Design patent drops out of the picture. 
 
Post-Traffix, strong Sears/Compco view is ascendant on the utility patent side: TM
shouldn’t be in utility patent’s sandbox. 
Both protection and nonprotection decisions are meaningful decisions
about competition.  Useful features, not
patentable features; patents are a cheat sheet but ultimately we’re concerned
about utility.  No return to Sears/Compco
on the aesthetic
side; it’s all about competitive need. So there’s room for movement, especially
w/heavier use of design patent. 
Corresponded to otherwise broadening trends in TM law, so conflict is more
significant than it’s ever been.
 
Why only patent law? 
It shouldn’t be. We’ll see other thinking about TM/© interface per Dastar. 
Why only restrict TM? That’s a useful and important Q, and other systems
should consider their own boundaries. One obvious point about comfort w/utility
patent: the short term has always been a prominent part of the discussion; TM
by definition doesn’t. Infringement standards are also different—no all
elements rule/less identity required to infringe. 
 
Discussant:  Lionel Bently: Utility patents are patents in
the EU; there are also Community registered designs (25 years) and unregistered
designs (3 years automatic from when made available).  National systems also have national
registered designs, also 25 years; some have national unregistered design
right, UK’s lasts 10 years for shape/configuration of product, not surface
decoration. © is now required to be capable of being cumulative w/design
rights.  TM protection for registered
marks at Community and national level, as well as possible national unfair
competition laws that extend to copying; specifically left open in ECJ TM
judgment.
 
Functionality
historically emerged as a way to encourage people to use utility patents to
cover nonappearance aspects of design instead of design for appearance aspects.
1839: Britain first covers design, including shape/configuration of product.
Patent system existed was expensive and involved required stages.  People tried to claim utilitarian aspects
through designs.  Registrar thought they
shouldn’t be used that way. New legislation in 1842 limited the register to
ornamental design, and in 1843, to cope with demand, created new system for
utility designs.  This was literally a
channeling device.  In two stages, the
legislation introduced functionality. 
Finally turns up in 1919 as amendment to 1907 Act: features dictated by
function shouldn’t be in the design system, designed to turf them back out to
patent.  Very clearly a channeling device
to get things into patent law, b/c of registered design system. 
 
Whether that
continues into the European image, he’s not sure.
 
What about TM? For
that, he doesn’t buy this channeling stuff. It’s TM policy: ordinary word marks
provide information benefits when protected, and there are no harms b/c taking
the words doesn’t do any harm.  Once you move
to product features, there is depletion/harm that then has to be balanced.  In that case, you might not want the
functionality test to be the same as between design and TM.
 
Design is about new
appearances for products. People motivated to produce new technical effect aren’t
motivated to produce new appearance. 
This test accords well w/policy justifications for designs, though
intent is a messy test.  IP systems apart
from TM are largely designed to produce intentional behavior/investment.  So focusing on people’s intentions doesn’t
seem necessarily inappropriate.  So I’d
have a broad notion of design functionality, and an even broader notion of TM
functionality.  I’ve always liked the
standard that something is problematic as a TM where it confers any significant
non-reputation-related advantage on the claimant. 
 
Dogan: I don’t think
that’s very broad.
 
McKenna: Agree.
 
Dogan: as long as
there are alternatives that work plausibly well in the marketplace, feature
protection is allowed. Quite generous for protection, relative to what we have
now for features that make product work.
 
Lemley: disagree as
practical matter. Narrow limiting piece: essential to production of
article.  Or affects cost/quality. I
understand Bently’s test to be an effort to adapt “cost or quality” into the
aesthetic framework.
 
McGeveran: a
nonutilitarian gloss.
 
Dogan: relative to
what?
 
Lemley: Significant
is the question; but that’s implicitly there anywhere. You could make the
argument that the Coke can is better than non-Coke b/c people like the color
red; that’s not going to fly. The key is the non-reputation-related
disadvantage, to distinguish b/t I want this b/c it looks nice and b/c I like
the TM owner.
 
Dinwoodie:
channeling part of Inwood is the first part. 
Qualitex: strange “that is” language between Inwood and substantial
non-reputation-related disadvantage; that can be very broad if you read it that
way.
 
Dogan: if we think channeling
has a value, how we think about design patents: Sympathetic to channeling in
utility patents. Post-Traffix, courts
have taken a pretty good approach; no evidence that there’ve been disastrous
cases.  In design that’s harder, b/c if
we accept design TMs at all, then there’s overlap by definition. McKenna came
around to election; that’s the only real alternative if we want some
separation/deference.  If we want design
patent to incentivize design, then we have to have the same quid pro quo: after
a time, it’s free to the public. That does lead her to election. If you take
advantage of that system, we should take at face value your claim that your
design has value, intrinsically, which then gets us to all these designs
presumptively meeting Bently’s standard. 
 
Bone: can be useful
to separate aesthetic value from generous view of secondary meaning. Source
identification can be part of what it makes the thing aesthetically attractive.
We’re not sure exactly what we’re channeling and where.  Sears/Compco dividing the world won’t work
because there are other policies that will be stomped on. Trade secret: there
are nonincentive reasons to have trade secret law. Policies that patent doesn’t
take account of that we nonetheless want to operate in this domain, and that
gets us to TM.  We may question whether
TM policy is effected by giving protection in this regime, but it at least
could do so.  Rule-like protection might
be the best balance, but we have to argue that.
 
Kur: History of
European design legislation—she was involved. 
There was definitely no channeling purpose at all, at least for current
design legislation.  It was only to
incentivize product diversification, not aesthetics.  Aesthetic is the wrong term, except very
broadly—capacity to communicate difference from what is already there.  [Making me even more confused about why
Europeans insist TM has a product differentiation function.]  Unless feature is strictly necessary for
function, protection is allowed. 
Practice has developed differently. 
Inner logic: there is no reason to exclude anything other than mandatory
shapes.
 
RT: Dogan says: Your
claim by registering design is that your design has value: is that what you’re
claiming? Why not: don’t copy my stuff? 
An anticopying norm as described by Kur for Germany in the last session doesn’t
have to have an incentive benefit, and it’s also consistent with her account of
European design.  Maybe it’s just a
private reward. Though I think that is  a
bad idea, but coherent.
 
My preferred version
of the aesthetic functionality test is a counterfactual: would the element have
marketplace value if the plaintiff didn’t exist? Makes sense of most cases,
though you then need another explanation for why Betty Boop case should come
out as a D victory; also allows you to do defendant side functionality as in
Louboutin, where there’s an obvious reason to have an all-red shoe even in a
world without Louboutin: the counterfactual test allows you to remove the “reputation
related advantage” and we’re trying to see whether there’s any advantage left
after that’s done.
 
Dinwoodie: throw Dastar into functionality mix. 
 
McKenna: skeptical
that courts are willing to pull the trigger on aesthetic functionality.  If we had a more limited design patent
regime, there’d be less overlap, but now you can get a design patent on a logo
on a screen.
 
McGeveran: Not sure
there’s much disagreement in the room: not a pure channeling v. non-channeling
divide.  Channeling is something courts
use as a heuristic to reach policy-driven outcomes in a quicker way.  Bently’s history is one reason channeling
occurs: institutional design/maneuvering around a bureaucracy.  Another is the heuristic.
 
Yen: What if some
people might like Gs on their bags even if Gucci didn’t exist, but very few?
How would that work?
 
RT: I think that’s
incorporated in substantial non-reputation related dis/advantage.  Higher level of abstraction can be used for
Louboutin: people predictably like single-color shoes.
 
McKenna: Justin
Hughes argues that a preexisting aesthetic preference is required for aesthetic
functionality—in many cases the P creates the demand/aesthetic preference.  [I think this is similar to but not as
helpful as the counterfactual, b/c we can’t easily figure out what preferences
were, and also b/c it’s possible that a few people would prefer, say, linked Gs
on their luggage even before Gucci launched, b/c their intials are G.]
 
McGeveran:
attractive is a lot harder to measure than useful in other ways. 
 
Dogan: most product
designs are intended to be attractive in some ways. Gucci may be a good example
of not being intended to be attractive: both to reflect source and to be attractive.  [This might be an example of distinguishing
b/t the word/symbol mark and the design
of a Gucci bag, which is probably, yes, designed to be attractive—but maybe
product design generally just shouldn’t be protected.]
 
McGeveran:
Green-gold pukey color in Qualitex likely
wasn’t chosen for attractiveness, but rather for distinctiveness.  [Though might be different for clothing,
where color plays a different role—it would make sense to have different
amounts of functionality in different markets.]
 
Dogan: need to know
how to measure value and in what market even under counterfactual test. Red
sole w/contrasting upper might make high heeled shoes look sexier. We struggle
w/this question of distinguishing visual features of product appearance when
those should be protected v. free for all.
 
Jessica Silbey: election
as a matter of client counseling.  It’s a
common strategy to file for TM, design patent, utility patent together all the
time. If you’re going to be penalized for not doing this when you start out by
being deemed to have waived the protections you didn’t seek, that will
encourage overprotection at the client level.
 
If we start from the
idea that TM is not an anticopying regime, that concurrent uses are common—what
would concurrent trade dress uses look like the way we have concurrent uses of
protected TM words?  For aesthetic
functionality, you should be able to copy aesthetic features like Burberry
plaid, just as we imagine concurrent uses w/word marks, protected in separate
markets, but it’s hard to do that with aesthetic functionality.  So if you start by saying TM isn’t
anticopying, both product design protection and aesthetic functionality (nonetheless?-
stop copying in many circumstances.
 
Alex Roberts: can we
fold registration into this discussion? 
Expectation is that litigation and registration scope would match up,
though we know that’s not true in practice, especially w/r/t trade dress.
 
Kur: once the regime
itself is flawed, the threshold doesn’t correspond to the contents of the
regime, then we have a big problem even in the absence of overlaps. 
 
Max Planck center
proposed to abolish our equivalent of aesthetic functionality; it doesn’t
work.  We protect every little difference
as design, so it became nonsensical. Need another reason to not protect shapes
that provide inherent value, and we don’t have clear policies about why certain
things shouldn’t be protected.  Worse, we
make the assessment at the registration stage: whether it’s so appealing to the
public that it shouldn’t be protected—they may be unable to do that b/c it may
not be in use yet! And once the decision 
has been made, it’s there forever b/c acquired distinctiveness can’t
trump it.  Yet fashion is such that
people may like some things now and not even care for it in 10 years. 

from Blogger http://ift.tt/1XcDVxk

Posted in Uncategorized | Tagged , , | Leave a comment